For citations:
Krysanov I.S., Krysanova V.S., Ermakova V.Yu., Kurkin D.V., Kolosov Yu.A., Smolyaninova A.K., Plastinina L.V., Zvonkov E.E. Mosunetuzumab in relapsed or refractory follicular lymphoma: a budget impact analysis in real-world clinical practice. Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice. 2026;(1):110-123. (In Russ.) https://doi.org/10.37489/2588-0519-GCP-0019. EDN: LCOGGR
JATS XML







































